Practice
Fecal microbiota transplantation for recurrent Clostridium difficile infection
Susy S. Hota and Susan M. Poutanen
CMAJ June 18, 2018 190 (24) E746; DOI: https://doi.org/10.1503/cmaj.171454
Susy S. Hota
Department of Infection Prevention and Control (Hota), University Health Network; Department of Medicine (Hota), University of Toronto; Department of Microbiology (Poutanen), University Health Network and Mount Sinai Hospital; Department of Laboratory Medicine and Pathobiology (Poutanen), University of Toronto, Toronto, Ont.
MD MScSusan M. Poutanen
Department of Infection Prevention and Control (Hota), University Health Network; Department of Medicine (Hota), University of Toronto; Department of Microbiology (Poutanen), University Health Network and Mount Sinai Hospital; Department of Laboratory Medicine and Pathobiology (Poutanen), University of Toronto, Toronto, Ont.
MD MPHArticle Figures & Tables
There are no figures or tables available.
In this issue
Article tools
Fecal microbiota transplantation for recurrent Clostridium difficile infection
Susy S. Hota, Susan M. Poutanen
CMAJ Jun 2018, 190 (24) E746; DOI: 10.1503/cmaj.171454
Jump to section
- Article
- Fecal microbiota transplantation is an effective treatment for recurrent Clostridium difficile infection
- Most fecal microbiota transplantations are performed by gastroenterologists and infectious disease specialists
- Donors should be rigorously screened
- There are four ways to administer fecal microbiota transplantation
- The long-term health effects are unknown
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.
Podcast